Dustan H P
Hypertension. 1983 Sep-Oct;5(5 Pt 2):III26-30. doi: 10.1161/01.hyp.5.5_pt_2.iii26.
Diuretic therapy, by producing a negative salt and water balance, eliminates the false tolerance to sympatholytic drugs that often occurs during long-term monotherapy. This tolerance results from salt and water retention produced by the drugs. Review of published results suggests a primacy for arterial pressure reduction in this fluid because suppressed renal sympathetic activity should facilitate salt and water excretion through lessened alpha-adrenergic influence on tubular reabsorption, and beta-adrenergic inhibition would diminish renin release thus promoting natriuresis. The return of hypertension that characterizes the false tolerances seems paradoxical because these drugs cause venodilation, which should provide ample storage of expanded blood volume without affecting cardiac output. However, animal studies have suggested that dilated veins have decreased compliance; if that is so, in humans it would mean that fluid retention would be accompanied by a redistribution of blood into the central circulation, with a rise in cardiac output.
利尿疗法通过产生负性盐和水平衡,消除了长期单一疗法期间经常出现的对交感神经阻滞药的假性耐受。这种耐受是由药物引起的盐和水潴留导致的。对已发表结果的回顾表明,在这种体液中降低动脉压具有首要地位,因为抑制肾交感神经活动应通过减少α-肾上腺素能对肾小管重吸收的影响来促进盐和水的排泄,而β-肾上腺素能抑制会减少肾素释放,从而促进利钠作用。假性耐受所特有的高血压复发似乎自相矛盾,因为这些药物会引起静脉扩张,这应该能充分储存扩张的血容量而不影响心输出量。然而,动物研究表明,扩张的静脉顺应性降低;如果是这样,在人类中这将意味着液体潴留会伴随着血液重新分布到体循环中,导致心输出量增加。